• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维生素D受体(VDR)基因多态性与单倍型、与血浆25-羟基维生素D和1,25-二羟基维生素D的相互作用以及前列腺癌风险

Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk.

作者信息

Mikhak Bahar, Hunter David J, Spiegelman Donna, Platz Elizabeth A, Hollis Bruce W, Giovannucci Edward

机构信息

Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA.

出版信息

Prostate. 2007 Jun 15;67(9):911-23. doi: 10.1002/pros.20570.

DOI:10.1002/pros.20570
PMID:17440943
Abstract

BACKGROUND

The vitamin D receptor (VDR) is required for actions of vitamin D. The binding of 1,25-dihydroxyvitamin D to the VDR on prostatic epithelial cells prompts the regulation of cancer-related genes.

METHODS

We conducted a nested case-control study in the Health Professionals Follow-up Study to investigate the role of the VDR Cdx2, Fok1, and Bsm1 gene polymorphisms and associated haplotypes and their interaction with plasma vitamin D metabolites in relation to prostate cancer (PC) risk.

RESULTS

No association was found between these SNPs or their associated haplotypes and all PC subtypes except that haplotype 2 (A-f-b) with Cdx2 A, Fok1 f, and Bsm1 b alleles and haplotype 3 (A-F-B) with Cdx2 A, Fok1 F and Bsm1 B alleles compared to the most common haplotype (A-F-b), were associated with reduced risk of aggressive PC (high stage or Gleason sum > or =7; P = 0.02), both with two alleles suspected of being low risk. Carriers of the variant Cdx2 A allele who were deficient in plasma 25-hydroxyvitamin D (< or =15 ng/ml) compared to non-carriers with normal 25-hydroxyvitamin D, had a lower risk of total and poorly differentiated PCs (Gleason sum > or =7) (P for interaction = 0.02 and 0.04, respectively). Plasma 1,25-dihydroxyvitamin D deficiency (< or =26 pg/ml) was associated with a threefold risk of poorly differentiated PC (P for interaction = 0.01) when comparing carriers of the Cdx2 A allele to non-carriers with normal 1,25-dihydroxyvitamin D.

CONCLUSION

In this population of men, none of the VDR polymorphisms studied was associated with susceptibility to PC.

摘要

背景

维生素D受体(VDR)是维生素D发挥作用所必需的。1,25 - 二羟基维生素D与前列腺上皮细胞上的VDR结合可促使癌症相关基因的调控。

方法

我们在健康专业人员随访研究中进行了一项巢式病例对照研究,以调查VDR Cdx2、Fok1和Bsm1基因多态性及其相关单倍型的作用,以及它们与血浆维生素D代谢产物在前列腺癌(PC)风险方面的相互作用。

结果

除了与最常见单倍型(A - F - b)相比,携带Cdx2 A、Fok1 f和Bsm1 b等位基因的单倍型2(A - f - b)以及携带Cdx2 A、Fok1 F和Bsm1 B等位基因的单倍型3(A - F - B)与侵袭性PC(高分期或Gleason总分>或=7;P = 0.02)风险降低相关外,这些单核苷酸多态性(SNP)或其相关单倍型与所有PC亚型之间均未发现关联,这两种单倍型都有两个被怀疑为低风险的等位基因。与25 - 羟基维生素D正常的非携带者相比,血浆25 - 羟基维生素D缺乏(<或=15 ng/ml)的Cdx2 A等位基因变异携带者患总PC和低分化PC(Gleason总分>或=7)的风险较低(交互作用P分别为0.02和0.04)。当比较Cdx2 A等位基因携带者与1,25 - 二羟基维生素D正常的非携带者时,血浆1,25 - 二羟基维生素D缺乏(<或=26 pg/ml)与低分化PC风险增加三倍相关(交互作用P = 0.01)。

结论

在这群男性中,所研究的VDR多态性均与PC易感性无关。

相似文献

1
Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk.维生素D受体(VDR)基因多态性与单倍型、与血浆25-羟基维生素D和1,25-二羟基维生素D的相互作用以及前列腺癌风险
Prostate. 2007 Jun 15;67(9):911-23. doi: 10.1002/pros.20570.
2
A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.一项关于血浆维生素D代谢物、维生素D受体基因多态性与前列腺癌的前瞻性研究。
PLoS Med. 2007 Mar;4(3):e103. doi: 10.1371/journal.pmed.0040103.
3
The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature.维生素D受体(VDR)基因多态性与癌症的相关性:文献综述
Anticancer Res. 2009 Sep;29(9):3511-36.
4
Vitamin D Receptor Polymorphisms and Cancer.维生素 D 受体多态性与癌症。
Adv Exp Med Biol. 2020;1268:53-114. doi: 10.1007/978-3-030-46227-7_4.
5
Vitamin D receptor polymorphisms and cancer.维生素 D 受体多态性与癌症。
Adv Exp Med Biol. 2014;810:69-105. doi: 10.1007/978-1-4939-0437-2_5.
6
[The impact of VDR gene polymorphisms on obesity, metabolic changes, bone mass disorders and neoplastic processes].[维生素D受体基因多态性对肥胖、代谢变化、骨量紊乱及肿瘤发生过程的影响]
Pediatr Endocrinol Diabetes Metab. 2018;24(2):96-105. doi: 10.18544/PEDM-24.02.0108.
7
Association of vitamin D receptor gene polymorphisms with polycystic ovary syndrome among Indian women.印度女性中维生素D受体基因多态性与多囊卵巢综合征的关联
Indian J Med Res. 2015 Sep;142(3):276-85. doi: 10.4103/0971-5916.166587.
8
Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies.四项研究中维生素D受体多态性与卵巢癌风险
Cancer Res. 2009 Mar 1;69(5):1885-91. doi: 10.1158/0008-5472.CAN-08-3515. Epub 2009 Feb 17.
9
Cdx2 polymorphism affects the activities of vitamin D receptor in human breast cancer cell lines and human breast carcinomas.Cdx2基因多态性影响人乳腺癌细胞系及人乳腺癌组织中维生素D受体的活性。
PLoS One. 2015 Apr 7;10(4):e0124894. doi: 10.1371/journal.pone.0124894. eCollection 2015.
10
Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk.维生素D受体基因多态性、单倍型与绝经后乳腺癌风险
Breast Cancer Res. 2008;10(2):R31. doi: 10.1186/bcr1994. Epub 2008 Apr 17.

引用本文的文献

1
The double disparity: Vitamin D deficiency and lethal prostate cancer in black men.双重差异:黑人男性中的维生素D缺乏与致命性前列腺癌
J Steroid Biochem Mol Biol. 2025 Mar;247:106675. doi: 10.1016/j.jsbmb.2025.106675. Epub 2025 Jan 17.
2
Possible association of Vitamin D receptor, caudal-related homeobox 2 polymorphism with the risk of cancer.维生素D受体、尾相关同源盒2基因多态性与癌症风险的可能关联。
Int J Health Sci (Qassim). 2021 Mar-Apr;15(2):9-13.
3
The Association Between the Genetic SNP c.907+75C>T and Prostate Cancer Risk Is Modified by Tanning Potential.
SNP c.907+75C>T 与前列腺癌风险的关联受晒黑潜能的影响。
Cancer Genomics Proteomics. 2020 Nov-Dec;17(6):739-745. doi: 10.21873/cgp.20228.
4
The Association of a Novel Identified SNP With Prostate Cancer in African American Men.一种新型 SNP 与非裔美国男性前列腺癌的关联。
Cancer Genomics Proteomics. 2019 Jul-Aug;16(4):245-255. doi: 10.21873/cgp.20129.
5
Lack of association between the risk of prostate cancer and vitamin D receptor polymorphism: a meta-analysis of 27 published studies.前列腺癌风险与维生素D受体基因多态性之间不存在关联:对27项已发表研究的荟萃分析
Cancer Manag Res. 2018 Aug 1;10:2377-2387. doi: 10.2147/CMAR.S171305. eCollection 2018.
6
Updated analysis of vitamin D receptor gene FokI polymorphism and prostate cancer susceptibility.维生素D受体基因FokI多态性与前列腺癌易感性的更新分析。
Arch Med Sci. 2017 Oct;13(6):1449-1458. doi: 10.5114/aoms.2016.61793. Epub 2016 Aug 16.
7
DHPLC Elution Patterns of PCR Products Can Predict Prostate Cancer Susceptibility in African American Men.聚合酶链反应产物的变性高效液相色谱洗脱模式可预测非裔美国男性患前列腺癌的易感性。
Cancer Genomics Proteomics. 2017 Nov-Dec;14(6):461-467. doi: 10.21873/cgp.20056.
8
Plasma 25-Hydroxyvitamin D Concentration and Risk of Islet Autoimmunity.血浆25-羟基维生素D浓度与胰岛自身免疫风险
Diabetes. 2018 Jan;67(1):146-154. doi: 10.2337/db17-0802. Epub 2017 Oct 23.
9
Association between Serum 25-Hydroxy-Vitamin D and Aggressive Prostate Cancer in African American Men.非裔美国男性血清25-羟基维生素D与侵袭性前列腺癌之间的关联。
Nutrients. 2016 Dec 28;9(1):12. doi: 10.3390/nu9010012.
10
Association of Vitamin D receptor Fok I polymorphism with the risk of prostate cancer: a meta-analysis.维生素D受体Fok I基因多态性与前列腺癌风险的关联:一项荟萃分析。
Oncotarget. 2016 Nov 22;7(47):77878-77889. doi: 10.18632/oncotarget.12837.